These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 28941618)
21. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia. Carville KS; Grant KA; Sullivan SG; Fielding JE; Lane CR; Franklin L; Druce J; Kelly HA Vaccine; 2015 Jan; 33(2):341-5. PubMed ID: 25448093 [TBL] [Abstract][Full Text] [Related]
22. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Belongia EA; Sundaram ME; McClure DL; Meece JK; Ferdinands J; VanWormer JJ Vaccine; 2015 Jan; 33(1):246-51. PubMed ID: 24962752 [TBL] [Abstract][Full Text] [Related]
23. Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN). Baselga-Moreno V; Trushakova S; McNeil S; Sominina A; Nunes MC; Draganescu A; Unal S; Koul P; Kyncl J; Zhang T; Kuatbayeva A; Ben-Salah A; Burtseva E; Puig-Barberà J; Díez-Domingo J; BMC Public Health; 2019 May; 19(1):487. PubMed ID: 31046725 [TBL] [Abstract][Full Text] [Related]
24. Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection. Domnich A; Orsi A; Signori A; Chironna M; Manini I; Napoli C; Rizzo C; Panatto D; Icardi G Expert Rev Vaccines; 2024; 23(1):380-388. PubMed ID: 38494919 [TBL] [Abstract][Full Text] [Related]
25. Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19. Pebody R; Whitaker H; Zhao H; Andrews N; Ellis J; Donati M; Zambon M Vaccine; 2020 Jan; 38(2):173-179. PubMed ID: 31653528 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ; Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911 [TBL] [Abstract][Full Text] [Related]
28. The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case-control study, Spain, 2013/14 and 2014/15. Domínguez A; Soldevila N; Toledo D; Godoy P; Espejo E; Fernandez MA; Mayoral JM; Castilla J; Egurrola M; Tamames S; Astray J; Morales-Suárez-Varela M; Euro Surveill; 2017 Aug; 22(34):. PubMed ID: 28857047 [TBL] [Abstract][Full Text] [Related]
29. Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season. Mira-Iglesias A; López-Labrador FX; García-Rubio J; Mengual-Chuliá B; Tortajada-Girbés M; Mollar-Maseres J; Carballido-Fernández M; Schwarz-Chavarri G; Puig-Barberà J; Díez-Domingo J Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33514058 [TBL] [Abstract][Full Text] [Related]
30. Self-reported diabetes and herpes zoster are associated with a weak humoral response to the seasonal influenza A H1N1 vaccine antigen among the elderly. Akmatov MK; Riese P; Trittel S; May M; Prokein J; Illig T; Schindler C; Guzmán CA; Pessler F BMC Infect Dis; 2019 Jul; 19(1):656. PubMed ID: 31337344 [TBL] [Abstract][Full Text] [Related]
31. Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network. Puig-Barberà J; Mira-Iglesias A; Burtseva E; Cowling BJ; Serhat U; Ruiz-Palacios GM; Launay O; Kyncl J; Koul P; Siqueira MM; Sominina A; BMC Infect Dis; 2019 May; 19(1):415. PubMed ID: 31088481 [TBL] [Abstract][Full Text] [Related]
32. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051 [TBL] [Abstract][Full Text] [Related]
34. Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018. Bruxvoort KJ; Luo Y; Ackerson B; Tanenbaum HC; Sy LS; Gandhi A; Tseng HF Vaccine; 2019 Sep; 37(39):5807-5811. PubMed ID: 31445771 [TBL] [Abstract][Full Text] [Related]
35. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of repeated influenza vaccination among the elderly population with high annual vaccine uptake rates during the three consecutive A/H3N2 epidemics. Song JY; Noh JY; Lee JS; Wie SH; Kim YK; Lee J; Jeong HW; Kim SW; Lee SH; Park KH; Choi WS; Cheong HJ; Kim WJ Vaccine; 2020 Jan; 38(2):318-322. PubMed ID: 31690467 [TBL] [Abstract][Full Text] [Related]
38. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
39. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J; Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366 [TBL] [Abstract][Full Text] [Related]
40. Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes. Darvishian M; Dijkstra F; van Doorn E; Bijlsma MJ; Donker GA; de Lange MM; Cadenau LM; Hak E; Meijer A PLoS One; 2017; 12(1):e0169528. PubMed ID: 28068386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]